Head to Head Review: Teleflex (NYSE:TFX) & Oncologix Tech (NYSE:OCLG)

Teleflex (NYSE:TFX) and Oncologix Tech (OTCMKTS:OCLG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.

Insider and Institutional Ownership

90.1% of Teleflex shares are held by institutional investors. 2.4% of Teleflex shares are held by insiders. Comparatively, 39.9% of Oncologix Tech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Teleflex and Oncologix Tech’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Teleflex $2.45 billion 6.66 $200.80 million $9.90 35.60
Oncologix Tech N/A N/A N/A N/A N/A

Teleflex has higher revenue and earnings than Oncologix Tech.

Analyst Recommendations

This is a summary of recent recommendations for Teleflex and Oncologix Tech, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex 0 1 7 1 3.00
Oncologix Tech 0 0 0 0 N/A

Teleflex currently has a consensus price target of $386.11, suggesting a potential upside of 9.55%. Given Teleflex’s higher probable upside, equities research analysts plainly believe Teleflex is more favorable than Oncologix Tech.

Volatility & Risk

Teleflex has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Oncologix Tech has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500.

Dividends

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 0.4%. Oncologix Tech does not pay a dividend. Teleflex pays out 13.7% of its earnings in the form of a dividend.

Profitability

This table compares Teleflex and Oncologix Tech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Teleflex 17.36% 18.81% 7.96%
Oncologix Tech N/A N/A N/A

Summary

Teleflex beats Oncologix Tech on 9 of the 12 factors compared between the two stocks.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

About Oncologix Tech

Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.